AVA: ACB Vaccine Acceptance Project

The AVA project was a two- year community-based participatory research project led by Principal Investigator Dr. Josephine Etowa from 2021–2023. The goal of the AVA project was to increase confidence, uptake and access to the COVID-19 vaccine for ACB communities in the National Capital Region through meaningful engagement of the ACB community and providers in the design, implementation and evaluation of vaccine promotion and knowledge translation interventions. There was a need for ACB people to be a priority population group to receive the COVID-19 vaccination, since they were among the populations hit hardest by the disease.

Learn More:

Watch interviews with Dr. Etowa and others taken at the 2022 ACB Health and Wellness Event in this video (8 minutes)

Project Team

Project team information currently unavailable.

Share this project...

Project Details

Principal investigator(s)

Dr. Josephine Etowa, CO-Is: Ghose, B. Dabone, C. et al

Project Year(s)

2021, 2022, 2023

Project Status

Completed

Funding Agency